Multicenter Phase II Study of Sequential Radioembolization-Sorafenib Therapy for Inoperable Hepatocellular Carcinoma

BACKGROUND: The safety and tolerability of sequential radioembolization-sorafenib therapy is unknown. An open-label, single arm, investigator-initiated Phase II study (NCT0071279) was conducted at four Asia-Pacific centers to evaluate the safety and efficacy of sequential radioembolization-sorafenib...

Descripción completa

Detalles Bibliográficos
Autores principales: Chow, Pierce K. H., Poon, Donald Y. H., Khin, Maung-Win, Singh, Harjit, Han, Ho-Seong, Goh, Anthony S. W., Choo, Su-Pin, Lai, Hee-Kit, Lo, Richard H. G., Tay, Kiang-Hiong, Lim, Teong-Guan, Gandhi, Mihir, Tan, Say-Beng, Soo, Khee-Chee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3948695/
https://www.ncbi.nlm.nih.gov/pubmed/24614178
http://dx.doi.org/10.1371/journal.pone.0090909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3948695/
https://www.ncbi.nlm.nih.gov/pubmed/24614178
http://dx.doi.org/10.1371/journal.pone.0090909

Ejemplares similares